- Safety & Recalls
- Regulatory Updates
- Drug Coverage
- COPD
- Cardiovascular
- Obstetrics-Gynecology & Women's Health
- Ophthalmology
- Clinical Pharmacology
- Pediatrics
- Urology
- Pharmacy
- Idiopathic Pulmonary Fibrosis
- Diabetes and Endocrinology
- Allergy, Immunology, and ENT
- Musculoskeletal/Rheumatology
- Respiratory
- Psychiatry and Behavioral Health
- Dermatology
- Oncology
Bariatric surgery can help, but not cure, diabetes
Gastric bypass surgery can improve glycemic control in adults with type 2 diabetes, but doesn't cure diabetes, according to the largest community-based study of long-term diabetes outcomes after bariatric surgery, published online ahead of print in Obesity Surgery.
Gastric bypass surgery can improve glycemic control in adults with type 2 diabetes, but doesn’t cure diabetes, according to the largest community-based study of long-term diabetes outcomes after bariatric surgery, published online ahead of print in Obesity Surgery.
The multisite study tracked 4,434 adults at Kaiser Permanente Northern California, Kaiser Permanente Southern California, and HealthPartners from 1995 to 2008. The research arms of all 3 of these integrated healthcare delivery systems-and Group Health Research Institute, where the study’s results were analyzed-belong to the HMO Research Network. The patients had type 2 diabetes that was either controlled with medication or else uncontrolled, and they were also obese enough to be candidates for gastric bypass surgery.
“We found that for most of those people, diabetes either never remitted after gastric surgery or relapsed within 5 years,” principal investigator David E. Arterburn, MD, MPH, a general internist and associate investigator at Group Health Research Institute, in Seattle, told Formulary.
The main impetus of the study is the growing numbers of Americans who are obese and have type 2 diabetes, according to Dr Arterburn. “Also, researchers have been disappointed with the results from attempts to treat diabetes with intensive lifestyle changes and intensive medical management,” he said.
Meanwhile, prior research has shown that, at least in the short term, gastric bypass surgery can profoundly improve glycemic control in adults with type 2 diabetes-often even before they lose significant weight. “That led some people to think that gastric bypass surgery might be a ‘cure’ for diabetes,” Dr Arterburn explained. “But we wanted to see what happened in the longer term.”
It’s still not clear whether diabetes relapse happens because of gaining weight back or because of the underlying progression of diabetes. But patients’ weight-before and after surgery-was not strongly correlated with remission or relapse of diabetes in this population.
“Managed care and hospital decision-makers need to find the best ways to care for their many patients who are obese and have diabetes-ways that will serve those patients best in the long run,” Dr Arterburn said. “Of course prevention is the best medicine. And gastric bypass surgery isn’t for everyone. But for patients who are already obese and have diabetes, our results suggest that it’s never too early to start considering the surgery.
“Our results suggest that, after gastric surgery, diabetes remits for longer in those people whose diabetes was less severe and at an earlier stage when they had the surgery,” he added. â
Coalition promotes important acetaminophen dosing reminders
November 18th 2014It may come as a surprise that each year Americans catch approximately 1 billion colds, and the Centers for Disease Control and Prevention estimates that as many as 20% get the flu. This cold and flu season, 7 in 10 patients will reach for an over-the-counter (OTC) medicine to treat their coughs, stuffy noses, and sniffles. It’s an important time of the year to remind patients to double check their medicine labels so they don’t double up on medicines containing acetaminophen.
Support consumer access to specialty medications through value-based insurance design
June 30th 2014The driving force behind consumer cost-sharing provisions for specialty medications is the acquisition cost and not clinical value. This appears to be true for almost all public and private health plans, says a new report from researchers at the University of Michigan Center for Value-Based Insurance Design (V-BID Center) and the National Pharmaceutical Council (NPC).
Management of antipsychotic medication polypharmacy
June 13th 2013Within our healthcare-driven society, the increase in the identification and diagnosis of mental illnesses has led to a proportional increase in the prescribing of psychotropic medications. The prevalence of mental illnesses and subsequent treatment approaches may employ monotherapy as first-line treatment, but in many cases the use of combination of therapy can occur, leading to polypharmacy.1 Polypharmacy can be defined in several ways but it generally recognized as the use of multiple medications by one patient and the most common definition is the concurrent use of five more medications. The presence of polyharmacy has the potential to contribute to non-compliance, drug-drug interactions, medication errors, adverse events, or poor quality of life.
Medical innovation improves outcomes
June 12th 2013I have been diagnosed with stage 4 cancer of the pancreas, a disease that’s long been considered not just incurable, but almost impossible to treat-a recalcitrant disease that some practitioners feel has given oncology a bad name. I was told my life would be measured in weeks.
